Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chiodini

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
British Journal of Cancer|April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trialC Pacilio, A Morabito, F Nuzzo, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
ESMO Open|December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]L Arenare, R Di Liello, P De Placido, et al.
Journal of Endocrinological Investigation|May 24, 2022
First baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in ItalyD Pasquali, P Chiodini, V Simeon, et al.
ESMO Open|February 26, 2026
Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trialL Paracchini, A Velle, P Di Gennaro, et al.
ESMO Open|September 26, 2022
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trialE D Capoluongo, B Pellegrino, L Arenare, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
British Journal of Cancer|April 20, 2006
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trialC Pacilio, A Morabito, F Nuzzo, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
ESMO Open|December 1, 2024
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941]L Arenare, R Di Liello, P De Placido, et al.
Journal of Endocrinological Investigation|May 24, 2022
First baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in ItalyD Pasquali, P Chiodini, V Simeon, et al.
ESMO Open|February 26, 2026
Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trialL Paracchini, A Velle, P Di Gennaro, et al.
ESMO Open|September 26, 2022
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trialE D Capoluongo, B Pellegrino, L Arenare, et al.
Pageof 5